November 11, 2026 - 03:22

REDWOOD CITY, Calif., Nov. 10, 2026 -- Seer, Inc., a leader in proteomic insights, has shared its financial performance for the third quarter of 2026. The company reported a revenue of $4.0 million for the quarter, marking a significant increase from the $3.1 million recorded in the previous quarter. This upward trend highlights Seer's growing presence in the market and its ability to capitalize on emerging opportunities.
As of September 30, 2026, Seer boasts a strong financial position, with approximately $198.1 million in cash, cash equivalents, and investments. This solid cash reserve provides the company with a robust foundation for future growth and innovation in the proteomics sector.
In addition to the quarterly results, Seer has revised its revenue guidance for the full year 2026, reflecting its optimistic outlook and strategic initiatives. The company remains committed to delivering cutting-edge solutions to its partners and clients, reinforcing its status as a trusted player in the field.
November 10, 2026 - 12:56
Milken Institute Announces Upcoming Middle East and Africa SummitABU DHABI, United Arab Emirates, November 10, 2026--The Milken Institute has revealed plans for its eighth annual Middle East and Africa Summit, set to take place on December 7 and 8, 2026. This...
November 9, 2026 - 23:56
Better Home & Finance Reports Third Quarter 2026 Financial ResultsNEW YORK, November 09, 2026--Better Home & Finance Holding Company, an AI-driven mortgage and home equity finance firm, has released its financial results for the third quarter ending September 30,...
November 9, 2026 - 11:35
Sohu Reports Third Quarter 2026 Financial ResultsSohu.com Limited, a prominent Chinese online media platform and gaming group, has released its unaudited financial results for the third quarter ending September 30, 2026. The company has shown...
November 8, 2026 - 19:49
5 insightful analyst questions from McKesson’s Q3 CY2026 earnings callMcKesson`s third quarter results showcased ongoing strength in its primary pharmaceutical distribution and specialty services. The company reported impressive growth in its North American...